Cargando…
Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial
BACKGROUND Intestinal mast cells may cause gastrointestinal symptoms in patients with diarrhea-dominant irritable bowel syndrome (IBS). The objective of this study was to determine the effect of mesalazine on the number of lamina propria mast cells and clinical manifestations of patients with diarrh...
Autores principales: | Ghadir, Mohammad Reza, Poradineh, Mehri, Sotodeh, Masoud, Ansari, Reza, Kolahdoozan, Shadi, Hormati, Ahmad, Yousefi, Mohammad Hosein, Mirzaei, Samaneh, Vahedi, Homayoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308130/ https://www.ncbi.nlm.nih.gov/pubmed/28316762 http://dx.doi.org/10.15171/mejdd.2016.47 |
Ejemplares similares
-
Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons
por: Ghadir, Mohammad Reza, et al.
Publicado: (2016) -
Is the Prevalence of Celiac Disease Higher than the General Population in Inflammatory Bowel Diseaese?
por: Jandaghi, Elahe, et al.
Publicado: (2015) -
Study of cytomegalovirus infection in idiopathic infertility men referred to Shariati hospital, Tehran, Iran
por: Habibi, Masoud, et al.
Publicado: (2014) -
Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
por: Dorofeyev, Andrey E, et al.
Publicado: (2011) -
Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
por: Zhang, Fen-Ming, et al.
Publicado: (2019)